GBH’s SARS-COV-2 Nucleic Acid Test Kit (RT-PCR) is a qualitative in vitro nucleic acid amplification assay used to detect SARS-CoV-2 using reverse transcription PCR from nasopharyngeal swabs, bronchoalveolar lavage fluids (BALF) and sputa samples. The test kit is widely used for rapid detection and outbreak control of SARS-COV-2(COVID-19). With its high specificity, high sensitivity and rapid response, it can effectively assist the diagnosis of disease(novel coronavirus pneumonia) and improve the diagnosis efficiency.
• The kit can be used for the diagnoses of patients and close contacts with symptoms of COVID-19.
• Dual test targets (ORF-1ab and N) will rise the test efficiency and lower the error rate.
• Sample Type: nasopharyngeal swabs, bronchoalveolar lavage fluids (BALF), sputa
• 48 samples per package or 96 samples per package
• CE certified and approved for exportation
Product Features
• Sensitivity: the sensitivity of SARS-COV-2 can reach the level of 300 copies/ml
• Precision: small variations of inter and intra batches and reliable reproducibility of test results
• Anti-interference: Common exogenous medicines and possible endogenous materials inside the samples will not interfere the test results.
• Specificity: The test kit was designed according to the conserved sequences of SARS-CoV-2, which lead to high test rate and no cross reaction by other pathogens in the same location or with the same symptoms.
Storage
• PCR reagents: under -20℃ and avoiding repetitive freeze-thawing
• Nucleic acid extract reagents: enclosed environment with temperature 2~8℃.
Reagents from different batches are not interchangeable. Valid within 12 months.